Tutorials › CAS Exam 8 - Advanced Ratemaking › Financing Cost In Large Deductible Pricing

CAS Exam 8 · Large Deductible Operations and Security · Tutorial 688 of 989

Financing Cost In Large Deductible Pricing

Estimate the time value of reimbursement delays and collateral, then incorporate financing costs into large deductible pricing without double counting.

Advanced 10 min read

What You'll Learn

  • Calculate the present-value and accumulated cost of funding a delayed reimbursement.
  • Value financing costs when advances occur on different dates.
  • Compare cash collateral opportunity cost with letter-of-credit fees.
  • Distinguish financing charges from expected claims, collateral principal, and credit losses.
  • Identify common valuation-date and double-counting errors.

Why Financing Cost Matters

Under a large deductible arrangement, an insurer may pay claim amounts before receiving reimbursement from the policyholder. The timing gap ties up funds, even when the reimbursement is ultimately paid in full. Posted cash collateral can also have a financing cost: the funds are unavailable for other uses, or earn less than the insurer’s relevant funding or investment return. These costs belong in a pricing analysis, but they are not themselves claim costs or credit losses.

The central discipline is to identify the cash flows, choose a funding rate and a valuation date, and compare amounts on that same date. An accumulated financing charge at the reimbursement date and a present-value cost at the advance date are alternative ways to express the same time value. Adding both would count the same cost twice.

Definition: A financing cost is the economic cost of making funds unavailable or borrowing funds during a specified period. For an advance \(A\) made at time \(t\), fully reimbursed after \(\tau\) years, and funded at an effective annual rate \(i_f\), the present-value financing cost at time \(t\) is \(A(1-v_f^\tau)\), where \(v_f=1/(1+i_f)\). The equivalent accumulated cost at the reimbursement date is \(A((1+i_f)^\tau-1)\). These expressions assume the advance is fully reimbursed, the funding rate is constant over the period, and there are no other cash flows or fees.

Valuing the Reimbursement Delay

If an insurer advances \(A\) at time \(t\) and receives \(A\) at time \(t+\tau\), the advance is an outflow at \(t\), while the reimbursement is an inflow at \(t+\tau\). Discounting both to \(t\), the net cost is the advance less the present value of the reimbursement. This is a financing cost, not a reduction in the amount of the claim payment.

$$ \text{PV financing cost at }t =A-\frac{A}{(1+i_f)^\tau} =A(1-v_f^\tau). $$

Alternatively, if the question asks for the charge at the reimbursement date, the advance would have accumulated to \(A(1+i_f)^\tau\) under the funding assumption. The accumulated charge above the original advance is therefore \(A((1+i_f)^\tau-1)\). Discounting that charge to time \(t\) gives

$$ v_f^\tau A\big((1+i_f)^\tau-1\big) =A(1-v_f^\tau). $$

This identity explains why the two measures agree when stated at their respective dates. It also shows why the result depends on the selected funding rate and period. If the advance and reimbursement amounts differ, replace the future \(A\) with the actual reimbursement \(R\); the present-value net cash burden is then \(A-Rv_f^\tau\). If the rate changes over time, use the applicable product of period-specific discount factors rather than a single constant-rate factor.

Worked Example: Expected Cost for an Uncertain Reimbursement Amount

A hypothetical insurer advances a claim reimbursement at time 0 and receives the full amount exactly one year later. The amount \(A\) is $80,000 with probability 0.75 and $160,000 with probability 0.25. Assume an effective annual funding rate of 6%, a constant rate, and no fees or credit losses. The amount distribution is discrete as specified; no mortality assumption is relevant. Find the expected present-value financing cost at time 0 and the expected accumulated cost at the end of the year.

Method. First find the expected amount advanced. Because timing and the funding rate are the same in both outcomes, the cost formula is linear in \(A\), so the expected amount can be used in the formula.

Expected advance:

$$ E[A]=(0.75)(\$80{,}000)+(0.25)(\$160{,}000) =\$60{,}000+\$40{,}000 =\$100{,}000. $$

The one-year discount factor is \(v_f=1/1.06\). Thus the present-value cost at time 0 is

$$ E[A](1-v_f) =\$100{,}000\left(1-\frac{1}{1.06}\right) =\$100{,}000\left(\frac{0.06}{1.06}\right) =\$5{,}660.377\ldots \approx \$5{,}660.38. $$

At the end of the year, the accumulated financing charge is

$$ E[A](1.06-1) =\$100{,}000(0.06) =\$6{,}000.00. $$

The check is that discounting $6,000 by 1.06 gives $5,660.377…; rounded to the nearest cent, it is $5,660.38. The two results differ because they are expressed at different dates, not because they are different costs. The mistake to avoid is adding $6,000 to $5,660.38: that would count the same financing cost twice.

Aligning Costs at a Common Valuation Date

When advances occur on different dates, their costs cannot simply be added if each is measured at its own advance date. Choose one common valuation date, then discount or accumulate every cost to it. For an advance \(A_j\) at time \(t_j\), reimbursed after \(\tau_j\) years, a constant effective annual funding rate \(i_f\), and valuation date 0, the present value is

$$ \text{PV}_0 =\sum_j A_j(1+i_f)^{-t_j} \left(1-(1+i_f)^{-\tau_j}\right). $$

This formula first calculates the cost at each advance date and then discounts that cost back to time 0. It assumes the stated advances and full reimbursements are the relevant cash flows. For uncertain amounts or timing, calculate the expected value of the appropriately discounted cash flows under the model assumptions; do not substitute a single average delay without checking whether it represents the cash-flow pattern.

Worked Example: Two Advances on Different Dates

A hypothetical insurer makes a $40,000 advance at time 0 and receives full reimbursement at time 1. It makes a separate $60,000 advance at time 1 and receives full reimbursement at time 3. Assume an effective annual funding rate of 10%, deterministic amounts and dates, no fees, and no credit losses. Find the total present-value financing cost at time 0. No mortality assumption is relevant.

Method. Calculate each cost at its own advance date, then bring the second cost back one year to time 0. The first advance has a one-year delay; the second has a two-year delay.

For the first advance, the time-0 cost is

$$ \$40{,}000\left(1-\frac{1}{1.10}\right) =\$40{,}000\left(\frac{1}{11}\right) =\$3{,}636.3636\ldots $$

For the second advance, the cost at time 1 is

$$ \$60{,}000\left(1-\frac{1}{(1.10)^2}\right) =\$60{,}000\left(1-\frac{1}{1.21}\right) =\$60{,}000\left(\frac{21}{121}\right) =\$10{,}413.2231\ldots $$

That second cost is at time 1, so its time-0 value is

$$ \frac{\$10{,}413.2231\ldots}{1.10} =\$9{,}466.5665\ldots $$

Adding the unrounded time-0 amounts gives

$$ \$3{,}636.3636\ldots+\$9{,}466.5665\ldots =\$13{,}102.9302\ldots \approx \$13{,}102.93. $$

The check is that both terms in the sum are valued at time 0. A common mistake is to add the first cost at time 0 to the second cost at time 1, producing a sum of amounts from different dates. Rounding each cost before adding can also produce a cent-level discrepancy; retain precision and round the final total to the nearest cent.

Cost of Posted Collateral

Posted collateral is not automatically an expense equal to its face amount. Cash collateral is usually returned if the obligation is satisfied, so its principal is a temporary use of funds rather than a claim cost. Its financing cost depends on the return earned on the collateral compared with the insurer’s relevant funding or opportunity rate. If the cash collateral earns the same effective rate as the applicable funding rate, this particular opportunity-cost measure is zero. If it earns less, the difference represents a cost of tying up funds.

A letter of credit (LOC) generally creates a different cash-flow pattern. Its fees, including any setup or renewal fees, are financing or security-related costs. Any potential draw, reimbursement default, or shortfall is a separate credit-risk issue. Keep the cost categories distinct: an expected credit-loss estimate is not a substitute for the fee or opportunity cost, and adding an expected credit-loss load to the financing charge should not duplicate either item.

Worked Example: Comparing Cash Collateral With a Letter of Credit

A hypothetical insured must provide $100,000 of security for one year. Under option A, it posts cash that earns 2% effective annually; the insurer’s relevant effective annual opportunity rate is 7%. Under option B, it provides an LOC with a $300 setup fee paid immediately and a 1.25% annual fee on the $100,000 face amount, paid at the end of the year. Assume the cash is returned after one year, there are no other fees or collateral requirements, and no credit losses occur. Find the present-value financing or fee cost of each option at time 0. The cash-flow assumptions are deterministic; no mortality assumption is relevant.

Cash collateral. At the end of the year, the $100,000 would have grown to $107,000 at the opportunity rate. The collateral instead grows to $102,000. The difference at year-end is therefore

$$ \$100{,}000(1.07)-\$100{,}000(1.02) =\$107{,}000-\$102{,}000 =\$5{,}000. $$

Discounting this difference to time 0 at 7% gives

$$ \frac{\$5{,}000}{1.07} =\$4{,}672.8971\ldots \approx \$4{,}672.90. $$

Letter of credit. The annual fee is \(0.0125(\$100{,}000)=\$1{,}250\), payable at year-end. Its time-0 present value, including the immediate setup fee, is

$$ \$300+\frac{\$1{,}250}{1.07} =\$300+\$1{,}168.2242\ldots =\$1{,}468.2242\ldots \approx \$1{,}468.22. $$

On the stated assumptions, the LOC has the lower present-value cost by \(\$4{,}672.8971\ldots-\$1{,}468.2242\ldots=\$3{,}204.6729\ldots\), or $3,204.67 to the nearest cent. This is a financing-cost comparison only; it does not establish that either security method is adequate or that the LOC has no operational or credit risk.

Incorporating the Cost in Pricing

A pricing indication can include financing cost alongside expected claim costs and other relevant expenses, provided each component has a clear definition and a consistent valuation basis. For example, if expected claim costs are measured at a particular date, bring financing costs to that date before combining them. A financing cost should reflect the expected advance and reimbursement cash flows, the applicable funding rate, and the timing assumption—not the full amount of collateral or reimbursement principal.

The following distinctions help prevent double counting:

  • Expected claim cost: the expected amount of covered claims or reimbursements under the chosen claim-cost basis.
  • Financing cost: the time value of funds advanced or tied up, or stated fees for obtaining financing or security.
  • Expected credit loss: the expected shortfall from a counterparty failing to reimburse, under the applicable credit-risk assumptions.
  • Collateral principal: funds temporarily committed as security. Do not treat the recoverable principal itself as an expense.

The practical input is often a projected pattern of advances, recoveries, and collateral releases. If the amount or timing is uncertain, use an explicit cash-flow model or scenario distribution and calculate the expected discounted costs. A single average delay may be inadequate when larger advances tend to remain outstanding longer, or when collateral releases depend on claim development.

Common Exam Traps

  • Mixing valuation dates. A cost at an advance date and a cost at a later reimbursement date cannot be added until both are converted to one date.
  • Counting the same cost twice. Use either the present-value difference \(A(1-v_f^\tau)\) or the accumulated charge \(A((1+i_f)^\tau-1)\), as appropriate to the requested date—not both.
  • Charging collateral principal as an expense. If principal is returned, measure the return foregone or the actual fees, not the whole amount posted.
  • Using the wrong rate. State whether the rate is an effective annual funding or opportunity rate and match it to the time unit in the delay.
  • Rounding intermediate values. Keep full precision through the calculation and round only the final reported amount.
Key takeaway: Financing cost is a time-value or fee component of large deductible pricing. Specify the cash flows, funding assumption, and valuation date; then keep financing cost separate from expected claim cost, recoverable collateral principal, and expected credit loss.

Check Your Understanding

For each problem, state or use the specified valuation date and round dollar amounts to the nearest cent.

  1. A hypothetical insurer advances $25,000 and receives full reimbursement one year later. At an effective annual funding rate of 8%, find the present-value financing cost at the advance date. Assume deterministic timing and amount, no fees, and no credit loss. (Answer: $1,851.85)
  2. A $70,000 advance is fully reimbursed two years later. The effective annual funding rate is 5%. Find the present-value financing cost at the advance date. Assume a constant rate and deterministic cash flows. (Answer: $6,507.94)
  3. An insurer advances $30,000 at time 0 and receives it at time 1. It advances another $50,000 at time 2 and receives it at time 3. At an effective annual funding rate of 10%, find the total present-value financing cost at time 0. Assume deterministic amounts and dates, no fees, and no credit losses. (Answer: $6,483.85)
  4. A business posts $80,000 in cash collateral for one year. The collateral earns 3% effective annually, while the relevant effective annual opportunity rate is 8%. Find the present value at time 0 of the one-year opportunity cost. Assume the collateral is returned at year-end and earns interest as stated. (Answer: $3,703.70)
  5. An advance amount is $50,000 with probability 0.40 and $100,000 with probability 0.60. The full amount is reimbursed exactly one year later, and the effective annual funding rate is 6%. Find the expected present-value financing cost at the advance date. Assume the specified discrete amount distribution, deterministic one-year timing, and no fees or credit losses. (Answer: $4,528.30)
Clinical Biostats